Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: Results from the French National Health Data System
Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: Results from the French National Health Data System. // Joint Bone Spine. – URL: https://www.sciencedirect.com/science/article/pii/S1297319X26001168?dgcid=rss_sd_all
Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: Results from the French National Health Data System. Joint Bone Spine. https://www.sciencedirect.com/science/article/pii/S1297319X26001168?dgcid=rss_sd_all
“Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: Results from the French National Health Data System.” Joint Bone Spine.
@article{article51241,
title = {Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: Results from the French National Health Data System},
journal = {Joint Bone Spine},
url = {https://www.sciencedirect.com/science/article/pii/S1297319X26001168?dgcid=rss_sd_all}
}